Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorUniversity of California, San Diego
About this trial
This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Aged 18-35
Plan to initiate testosterone therapy
Disqualifiers
Pregnant
Incarcerated
Known cognitive impairment or institutionalized
Hemoglobin less than 11 gm/dl at screening evaluation
Trial design
Treatments tested in this trial
- Testosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, San Diego
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Source ClinicalTrials.gov